Select your Market

Global
Global
CAREERS

Rare Tumors

With an expanding portfolio, our Rare Tumors therapeutic area centers on patients whose lives are profoundly affected by chronic symptoms, pain, frequent procedures, and uncertain future.

Ultimate goal: preserve and restore function

Some rare tumors are often described in clinical terms as "non-malignant." For patients, however, they are anything but benign. These diseases do not typically metastasize, but they can take over a patient's life.

A clear path to better daily living that extends beyond radiographic change alone, defines our approach for desmoid tumors, Neurofibromatosis type 1 associated plexiform neurofibromas (NF1-PN) and Tenosynovial giant cell tumor (TGCT). We are collaborating with clinicians, researchers and patients to improve outcomes, and ultimately seek for preservation and restoration of function.
 

KEY DISEASE AREAS